These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


665 related items for PubMed ID: 17617122

  • 1. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
    Clemente C, Elba S, Buongiorno G, Guerra V, D'Attoma B, Orlando A, Russo F.
    Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
    [Abstract] [Full Text] [Related]

  • 2. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Dény P, Trinchet JC, Callard P, Guettier C, Beaugrand M.
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

  • 5. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU, Semelka RC, Pamuklar E, Firat Z, Gerber RD, Shrestha R, Russo MW.
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
    Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF.
    Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
    [Abstract] [Full Text] [Related]

  • 7. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Martínez I, Rodrigo L.
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [Abstract] [Full Text] [Related]

  • 8. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time trends in the incidence of hepatocellular carcinoma in liver cirrhosis. A retrospective necropsy study in a large Romanian town (1973-1992).
    Acalovschi M, Pascu M, Iobagiu S, Ban A, Olinici DC, Petrescu M.
    Rom J Intern Med; 1996 Jul; 34(1-2):85-90. PubMed ID: 8908635
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M.
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.
    Am J Gastroenterol; 2001 May; 96(5):1575-80. PubMed ID: 11374702
    [Abstract] [Full Text] [Related]

  • 18. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A, Piscaglia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD.
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [Abstract] [Full Text] [Related]

  • 19. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y, Shiraki K, Sugimoto K, Ito T, Yamanaka T, Fujikawa K, Takase K, Nakano T.
    Anticancer Res; 2000 Feb; 20(5C):3709-15. PubMed ID: 11268443
    [Abstract] [Full Text] [Related]

  • 20. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K, Fujiyama S, Ohkawa S, Miyakawa K, Tamai S, Hirokawa S, Masaki T, Tanaka K.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.